NEW YORK, April 18 - Lynx Therapeutics today said it has cut approximately 30 percent of its domestic workforce, or 60 people, and said it expects to focus more on its MPSS gene-expression technology and on the development of its Protein ProFiler proteomics technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.